Analytical Data
-
Gene name
BTBD11
- Application
-
Alternative Names
BTBD11; Ankyrin repeat and BTB/POZ domain-containing protein BTBD11; BTB/POZ domain-containing protein 11
-
Species
Human
-
Source
Baculovirus
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6QL63
-
Expression Region
A2-V1104
-
Protein Length
Full Length
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BTBD11 (BTB domain containing 11) is a member of the BTB/POZ protein family, which is known to play significant roles in various biological processes, including gene regulation, protein-protein interactions, and the assembly of multiprotein complexes. Recent studies have highlighted its involvement in essential cellular functions and its potential implications in human diseases, particularly in the context of cancer and developmental disorders. Research has shown that BTBD11 can act as a transcriptional regulator, influencing gene expression patterns critical for cell differentiation and proliferation. Additionally, dysregulation of BTBD11 has been associated with oncogenic pathways, making it a candidate for further investigation as a therapeutic target. Given its intriguing structural features and functional versatility, the recombinant production of BTBD11 protein has become a focal point in the field of molecular biology, allowing for in-depth studies into its biochemical properties and interactions with other cellular components. Understanding the functional mechanisms of BTBD11 through recombinant protein studies may shed light on its role in various pathophysiological conditions and contribute to the development of novel therapeutic strategies.
